賓夕法尼亞州韋恩和上海2025年8月7日 /美通社/ -- 泰利福公司（NYSE: TFX），全球領先的醫療技術公司，今日宣布其旗下Rüsch? EZ-Blocker? 一次性使用雙側支氣管堵塞器已成功通過中國國家藥品監督管理局（NMPA）的嚴格審評審批，并正式取得醫療器械注冊證（注冊證編號：國械注進20252080316）。這不僅是泰利福中國產品組合的一次重要升級優化，更為公司在華業務的增長注入強勁動力。
泰利福Rüsch? EZ-Blocker?一次性使用雙側支氣管堵塞器
泰利福中國始終致力于為全球醫療市場提供創新的醫療解決方案，此次 Rüsch? EZ-Blocker?一次性使用雙側支氣管堵塞器在華獲批，是泰利福深耕中國市場、滿足中國患者醫療需求的又一重要舉措。未來，泰利福將繼續優化其在中國的產品組合，為推動中國醫療健康事業的發展貢獻更多力量。
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in the world of healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow?, Barrigel?, Deknatel?, LMA?, Pilling?, QuikClot?, Rüsch?, UroLift? and Weck? – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.
© 2025 Teleflex Incorporated. All rights reserved. MCC-2025-0101
Contacts:
Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investor.relations@teleflex.com
610-948-2836
Teleflex China
Yolanda Li (李婪)
Marketing Communications Supervisor (市場傳播主管), China
yolanda.li@teleflex.com
+86 021 6060 6918
